# Shenyang Tianfeng Bio-Pharm Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenyang-tianfeng-bio-pharm-co

- Industry: Biotechnology
- Headquarters: Shenyang, China
- Website: www.taxol.com.cn/
- Latest round: Series B (Jan 7, 2026)
- Investors on record: 1

## About

Based in Shenyang, China and founded in 2005, Shenyang Tianfeng Bio-Pharm Co., Ltd. provides phospholipid-based ingredients for the healthcare industry. The company was established to develop high end natural phospholipids and has since expanded its capabilities to include bioconversion technologies and custom application solutions. In January 2026, the company closed a series B funding from Zhongtian Liaochuang Investment.

The company works with pharmaceutical manufacturers, food producers, and cosmetic companies to provide specialized ingredient solutions. Additionally, the firm offers custom formulations and application technology services to meet specific client requirements.

The company’s revenue is generated by the direct sale of phospholipid products to industrial clients.

The company plans to use the recent series B funding to expand its production lines and enhance its market presence.

## Funding rounds

- Series B, Jan 7, 2026 — Zhongtian Liaochuang Investment

## Investors

- Zhongtian Liaochuang Investment — Series B